Novanta Inc. Relocates Principal Executive Offices
Ticker: NOVTU · Form: 8-K · Filed: Dec 1, 2025 · CIK: 1076930
| Field | Detail |
|---|---|
| Company | Novanta Inc (NOVTU) |
| Form Type | 8-K |
| Filed Date | Dec 1, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-action, filing-update
Related Tickers: NOV
TL;DR
NOVANTA INC. MOVED ITS HQ TO BEDFORD, MA.
AI Summary
On December 1, 2025, Novanta Inc. filed an 8-K report. The filing indicates a change in the company's principal executive offices to 125 Middlesex Turnpike, Bedford, Massachusetts 01730. The company's former name was GSI Group Inc., with a name change date of June 22, 2005.
Why It Matters
This filing signals a physical relocation of Novanta Inc.'s main operational hub, which could impact local employment and business operations.
Risk Assessment
Risk Level: low — The filing is a routine administrative update regarding office location and does not involve financial performance or strategic changes.
Key Players & Entities
- Novanta Inc. (company) — Registrant
- GSI Group Inc. (company) — Former company name
- 125 Middlesex Turnpike, Bedford, Massachusetts 01730 (location) — New principal executive offices
- June 22, 2005 (date) — Date of former company name change
FAQ
What is the new address for Novanta Inc.'s principal executive offices?
The new address for Novanta Inc.'s principal executive offices is 125 Middlesex Turnpike, Bedford, Massachusetts 01730.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on December 1, 2025.
What was Novanta Inc. formerly known as?
Novanta Inc. was formerly known as GSI Group Inc.
On what date did the company change its name from GSI Group Inc.?
The company changed its name from GSI Group Inc. on June 22, 2005.
What is the IRS Employer Identification Number for Novanta Inc.?
The IRS Employer Identification Number for Novanta Inc. is 98-0110412.
Filing Stats: 560 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-12-01 16:30:27
Filing Documents
- novt-20251201.htm (8-K) — 45KB
- 0001193125-25-303940.txt ( ) — 152KB
- novt-20251201.xsd (EX-101.SCH) — 29KB
- novt-20251201_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure Effective December 1, 2025, Novanta Inc. (the "Company") appointed Alexander Manganiello as General Counsel and Corporate Secretary. In this role, Mr. Manganiello will lead the Company's global legal, regulatory, corporate secretary, and trade compliance organizations. He brings to the Company 30 years of experience working with global, public companies across multiple industries. From 2019 until joining the Company, Mr. Manganiello was with Vertex Pharmaceuticals Incorporated (NYSE: VRTX), most recently serving as Vertex's Vice President, Deputy General Counsel. From 2004 through 2019, Mr. Manganiello served in a variety of increasingly senior legal roles at Pfizer Inc. (NYSE: PFE). Prior to Pfizer, he practiced law within the corporate department of Ropes & Gray (Boston, MA). Mr. Manganiello holds an A.B., Biology from Harvard University and a J.D. from Suffolk Law School. The information contained in this Item 7.01 is furnished under Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Novanta Inc. Date: December 1, 2025 By: /s/ Robert J. Buckley Robert J. Buckley Chief Financial Officer